DaVita Inc
DVA134.690USD
+2.610+1.98%
Close 08/13, 16:00（ET）Quotes delayed by 15 min
10.00BMarket Cap
11.63P/E TTM
More Details of DaVita Inc Company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
Ticker SymbolDVA
Company nameDaVita Inc
IPO dateOct 31, 1995
CEOMr. Javier J. Rodriguez
Number of employees76000
Security typeOrdinary Share
Fiscal year-endOct 31
Address2000 16th St
CityDENVER
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code80202-5117
Phone13105362668
Websitehttps://www.davita.com/
Ticker SymbolDVA
IPO dateOct 31, 1995
CEOMr. Javier J. Rodriguez
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.58K
+1.38%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.28K
-14.14%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.20K
+2.71%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
12.66K
+2.83%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
6.45K
+5.70%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.58K
+1.38%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.61B
49.91%
Patient service - Commercial
1.01B
31.42%
Patient service - Other government
286.49M
8.89%
Patient service - Medicaid and Managed Medicaid
206.51M
6.41%
Other - Medicare and Medicare Advantage
98.95M
3.07%
Other
9.85M
0.31%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.61B
49.91%
Patient service - Commercial
1.01B
31.42%
Patient service - Other government
286.49M
8.89%
Patient service - Medicaid and Managed Medicaid
206.51M
6.41%
Other - Medicare and Medicare Advantage
98.95M
3.07%
Other
9.85M
0.31%
Shareholding Stats
Updated: 5 hours ago
Updated: 5 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
6.61%
BlackRock Institutional Trust Company, N.A.
3.69%
State Street Global Advisors (US)
3.07%
Weschler (R Ted)
3.05%
Other
38.59%
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
6.61%
BlackRock Institutional Trust Company, N.A.
3.69%
State Street Global Advisors (US)
3.07%
Weschler (R Ted)
3.05%
Other
38.59%
Shareholder Types
Shareholders
Proportion
Holding Company
44.99%
Investment Advisor
28.89%
Investment Advisor/Hedge Fund
13.90%
Individual Investor
5.00%
Hedge Fund
3.51%
Pension Fund
1.95%
Research Firm
1.68%
Bank and Trust
1.05%
Sovereign Wealth Fund
0.09%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1278
73.92M
100.87%
-6.43M
2025Q1
1300
76.19M
99.78%
-5.46M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
2023Q1
1168
84.01M
92.60%
-5.13M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Berkshire Hathaway Inc.
33.80M
44.76%
-1.35M
-3.83%
May 27, 2025
The Vanguard Group, Inc.
5.03M
6.67%
-160.20K
-3.08%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.91M
3.86%
-2.74K
-0.09%
Mar 31, 2025
State Street Global Advisors (US)
2.20M
2.91%
-147.00K
-6.27%
Mar 31, 2025
Weschler (R Ted)
2.18M
2.89%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.31M
1.73%
+73.07K
+5.91%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
1.57%
+36.68K
+3.19%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.32K
1.16%
-25.10K
-2.78%
Mar 31, 2025
LSV Asset Management
962.33K
1.27%
-66.10K
-6.43%
Mar 31, 2025
Rodriguez (Javier J)
837.84K
1.11%
-37.42K
-4.28%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Alpha Architect US Quantitative Value ETF
2.05%
Strategas Global Policy Opportunities ETF
1.98%
SPDR S&P Health Care Services ETF
1.97%
Aztlan Global Stock Selection DM SMID ETF
1.78%
Invesco S&P 500 Equal Weight Health Care ETF
1.71%
First Trust Health Care Alphadex Fund
1.65%
Pacer US Small Cap Cash Cows ETF
1.55%
Pacer US Cash Cows Growth ETF
1.43%
iShares U.S. Healthcare Providers ETF
0.93%
Global X Aging Population ETF
0.89%
View more
Alpha Architect US Quantitative Value ETF
Proportion2.05%
Strategas Global Policy Opportunities ETF
Proportion1.98%
SPDR S&P Health Care Services ETF
Proportion1.97%
Aztlan Global Stock Selection DM SMID ETF
Proportion1.78%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.71%
First Trust Health Care Alphadex Fund
Proportion1.65%
Pacer US Small Cap Cash Cows ETF
Proportion1.55%
Pacer US Cash Cows Growth ETF
Proportion1.43%
iShares U.S. Healthcare Providers ETF
Proportion0.93%
Global X Aging Population ETF
Proportion0.89%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
